Study conducted in living cells opens up new opportunities for the development of more effective therapies against different types of cancer, such as glioblastoma
More than half of cancer cases worldwide are associated with genetic mutations in p53, the protein responsible for protecting DNA from changes that can lead to cancer. When this protein deforms, it not only loses its protective capacity, but can also gain new functions, acting as a "traitor", and contributing to the spread of the tumor by forming protein clusters that may be resistant to chemotherapy.
The mechanisms by which this "betrayal" occurs and how it causes drug resistance are not yet fully understood.
A group of Brazilian researchers led by biochemist Jerson Lima Silva, professor at the Federal University of Rio de Janeiro (UFRJ), uncovered part of the mystery. In a new study, the scientists identified the presence of a large amount of the protein's traitor version in chemotherapy-resistant cells derived from glioblastoma, a super aggressive brain tumor.
They also found how the deformed protein are organized inside the cell to exert resistance: they form clumps larger than those found in healthy individuals, some with amyloid properties, that is, when mutation leads to clumps. These structures were observed in the nucleus of living cells for the first time. The results are published in iScience.
The use of living cells makes important contributions to research in the field.
"Unlike other studies, we identified small oligomers (structures a little larger than the healthy version of p53) in living cells, contributing to the identification of p53 aggregates more closely to what should occur in the human organism. This was possible because of the collaboration with researcher Enrico Gratton, who developed fluorescence fluctuation spectroscopy analysis," explains Murilo Pedrote, a graduate student at the National Institute of Science and Technology for Structural Biology and Bioimaging (INBEB) and first author of the study.
The research was conducted using a p53-specific mutation (M237I). "This is important because the native protein (without mutation) and other mutations are not capable of conferring the same drug resistance," says Guilherme A. P. de Oliveira, professor at UFRJ and one of the study's coordinators.
Lima Silva's group has been studying p53 mutations for over 15 years. His laboratory was the first to identify the propensity of the deformed protein to form amyloid aggregates, and that they play a crucial role in cancer development through loss of function, negative dominance (when mutated versions of the protein bind to healthy ones, altering their behavior) and gain of function.
After that, it was observed by different scientists that mutated p53 amyloid aggregates are present in breast, ovarian and prostate cancer. Due to their characteristics, these amyloid clusters have become a new target for anticancer therapy.
In the new study, Lima Silva, de Oliveira and the other authors found that, in glioblastoma, an aggressive, invasive brain tumor with low survival (14 months), the deformed protein is involved not only in the formation of amyloid aggregates, but also in the resistance to temozolomide, the main drug used to treat the disease.
The results are expected to enable the development of more effective treatments against various types of cancer. "Our study indicates that misfolded p53 and p53 aggregates are formidable targets for the development of new cancer treatment strategies," Lima Silva concludes.
The paper entitled "Oncogenic gain of function in glioblastoma is linked to mutant p53 amyloid oligomers" is published online in iScience.
The study was funded by the National Council for Scientific and Technological Development (CNPq), the Carlos Chagas Filho Foundation for Research Support in the State of Rio de Janeiro (FAPERJ), the Coordination of Improvement of Higher Education (CAPES / MEC) and the National Institute of Science and Technology for Structural Biology and Bioimaging (INBEB).
Jerson Lima Silva | EurekAlert!
Life's clockwork: Scientist shows how molecular engines keep us ticking
14.01.2020 | University of North Carolina Health Care
World Premiere in Zurich: Machine keeps human livers alive for one week outside of the body
14.01.2020 | Universitätsspital Zürich
Researchers from the University Hospital Zurich, ETH Zurich, Wyss Zurich and the University of Zurich have developed a machine that repairs injured human livers and keep them alive outside the body for one week. This breakthrough may increase the number of available organs for transplantation saving many lives of patients with severe liver diseases or cancer.
Until now, livers could be stored safely outside the body for only a few hours. With the novel perfusion technology, livers - and even injured livers - can now...
A balloon-borne scientific instrument designed to study the origin of cosmic rays is taking its second turn high above the continent of Antarctica three and a half weeks after its launch.
SuperTIGER (Super Trans-Iron Galactic Element Recorder) is designed to measure the rare, heavy elements in cosmic rays that hold clues about their origins...
One last time on Earth it has been turned on in France in December 2019. The next time the MOMA laser developed by the Laser Zentrum Hannover e.V. (LZH) is going into operation will be on Mars. The ExoMars rover into which the laser is integrated has now successfully passed the thermal vacuum tests at Airbus in Toulouse, France.
For 18 days the ExoMars rover Rosalind Franklin was subjected to thermal vacuum tests at Airbus. There, it had to withstand strong changes in temperature and...
The Atacama Desert in Chile is the oldest and most arid desert on earth. Organisms living in this area have adapted to the extreme conditions over thousands of years. A research team led by Dr Patrick Jung has now discovered and investigated a previously unknown biocoenosis of lichens, fungi, cyanobacteria and algae. It colonises tiny stones, so-called grit and its need for water is satisfied by fog and dew. These organisms also decompose the rock on and in which they live. The scientists believe that this is how they have shaped the landscape of the Atacama Desert. Their study was published in the renowned scientific journal "Gebiology".
Many desert areas have large black spots in the sand. These spots are mineral deposits, so-called desert varnish. In the Atacama Desert, which can be compared...
For the first time, physicists from the University of Würzburg have successfully converted electrical signals into photons and radiated them in specific directions using a low-footprint optical antenna that is only 800 nanometres in size.
Directional antennas convert electrical signals to radio waves and emit them in a particular direction, allowing increased performance and reduced...
07.01.2020 | Event News
19.12.2019 | Event News
03.12.2019 | Event News
14.01.2020 | Life Sciences
13.01.2020 | Physics and Astronomy
13.01.2020 | Life Sciences